Aurobindo Pharma arm CuraTeQ gets positive EMA opinion for biosimilar Zefylti
HYDERABAD: Aurobindo Pharma’s wholly-owned subsidiary, CuraTeQ Biologics Private Limited, received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European drug regulatory body, the European Medicines Agency (EMA), for its filgrastim biosimilar, Zefylti. The committee recommended granting marketing authorisation.The Hyderabad-based company stated that Zefylti is its first biosimilar to…